American Well Corporation (NYSE:AMWL) Given Consensus Rating of “Hold” by Analysts

Shares of American Well Corporation (NYSE:AMWL) have received an average rating of “Hold” from the seven research firms that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and one has issued a buy recommendation on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $7.40.

AMWL has been the topic of a number of research reports. Wall Street Zen upgraded American Well from a “sell” rating to a “hold” rating in a report on Sunday, March 22nd. Weiss Ratings reiterated a “sell (e+)” rating on shares of American Well in a research note on Wednesday, January 21st. Finally, Stifel Nicolaus lowered their target price on American Well from $6.00 to $5.00 and set a “hold” rating for the company in a research note on Friday, February 13th.

Insider Activity

In other news, insider Dmitry Zamansky sold 5,575 shares of the stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $5.30, for a total value of $29,547.50. Following the completion of the sale, the insider owned 241,080 shares in the company, valued at approximately $1,277,724. This trade represents a 2.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders sold a total of 9,664 shares of company stock valued at $51,219 in the last ninety days. 12.80% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On American Well

Large investors have recently modified their holdings of the stock. NewEdge Advisors LLC acquired a new stake in shares of American Well in the fourth quarter valued at about $82,000. XTX Topco Ltd acquired a new stake in shares of American Well in the fourth quarter valued at about $215,000. Occudo Quantitative Strategies LP acquired a new stake in shares of American Well in the fourth quarter valued at about $74,000. Barclays PLC grew its stake in shares of American Well by 67.7% in the fourth quarter. Barclays PLC now owns 24,047 shares of the company’s stock valued at $118,000 after buying an additional 9,705 shares in the last quarter. Finally, Prelude Capital Management LLC acquired a new stake in American Well during the 3rd quarter valued at approximately $86,000. Institutional investors and hedge funds own 56.05% of the company’s stock.

American Well Price Performance

American Well stock opened at $6.29 on Wednesday. The stock’s 50-day moving average is $5.55 and its 200-day moving average is $5.03. The company has a market cap of $104.12 million, a price-to-earnings ratio of -1.06 and a beta of 1.39. American Well has a 12 month low of $3.71 and a 12 month high of $9.15.

American Well (NYSE:AMWL) last released its quarterly earnings data on Thursday, February 12th. The company reported ($1.52) EPS for the quarter, topping analysts’ consensus estimates of ($1.59) by $0.07. The company had revenue of $55.31 million for the quarter, compared to the consensus estimate of $52.71 million. American Well had a negative return on equity of 35.33% and a negative net margin of 38.38%. Research analysts anticipate that American Well will post -2.88 EPS for the current year.

About American Well

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.